jvl associates llc acquired a new stake in Stryker Co. (NYSE:SYK - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 658 shares of the medical technology company's stock, valued at approximately $245,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC purchased a new stake in Stryker in the 4th quarter valued at $25,000. Capital A Wealth Management LLC purchased a new stake in Stryker in the 4th quarter valued at $26,000. Rakuten Securities Inc. grew its holdings in Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after buying an additional 68 shares in the last quarter. Centricity Wealth Management LLC purchased a new stake in Stryker in the 4th quarter valued at $30,000. Finally, BankPlus Trust Department purchased a new stake in Stryker in the 4th quarter valued at $33,000. 77.09% of the stock is owned by institutional investors and hedge funds.
Stryker Trading Up 0.1%
Stryker stock traded up $0.51 during midday trading on Friday, reaching $382.86. 1,993,145 shares of the stock traded hands, compared to its average volume of 1,342,825. The company has a 50-day simple moving average of $368.77 and a two-hundred day simple moving average of $376.22. Stryker Co. has a 12-month low of $314.93 and a 12-month high of $406.19. The firm has a market cap of $146.13 billion, a PE ratio of 49.34, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59.
Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a return on equity of 23.58% and a net margin of 13.25%. Stryker's revenue for the quarter was up 11.9% on a year-over-year basis. During the same period last year, the business posted $2.50 EPS. Research analysts expect that Stryker Co. will post 13.47 earnings per share for the current fiscal year.
Stryker Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.88%. The ex-dividend date of this dividend is Monday, June 30th. Stryker's dividend payout ratio is currently 45.41%.
Analyst Upgrades and Downgrades
Several analysts have issued reports on SYK shares. BTIG Research set a $403.00 target price on Stryker and gave the company a "buy" rating in a report on Monday, April 14th. Barclays upped their target price on Stryker from $418.00 to $443.00 and gave the company an "overweight" rating in a report on Monday, February 10th. Roth Mkm increased their price target on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. Evercore ISI lowered their price target on Stryker from $400.00 to $390.00 and set an "outperform" rating for the company in a report on Friday, May 2nd. Finally, Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a report on Thursday, March 6th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $427.30.
Check Out Our Latest Research Report on Stryker
Insider Buying and Selling at Stryker
In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 5.20% of the stock is owned by corporate insiders.
About Stryker
(
Free Report)
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Further Reading
Before you consider Stryker, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.
While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
